We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · April 18, 2021

The Migraine Treatment Landscape Prior to CGRP Inhibitors



Additional Info

Disclosure statements are available on the authors' profiles:

Understanding the Migraine Treatment Landscape Prior to the Introduction of Calcitonin Gene-Related Peptide Inhibitors: Results From the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients Using Preventive Treatment (ATTAIN) Study
Headache 2021 Mar 01;61(3)438-454, AK Kawata, N Shah, JL Poon, S Shaffer, S Sapra, TK Wilcox, S Shah, SJ Tepper, DW Dodick, RB Lipton

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading